Interactions of lactoferrin with cells involved in immune function

Biochemistry and Cell Biology

Volumn 84, Issue 3, 2006, Pages 282-290

  Legrand, Dominique ^a   Elass, Elisabeth ^a   Carpentier, Mathieu ^a   Mazurier, Joël ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Immunoregulation; Inflammation; Interactions with immune cells; Lactoferrin receptors

Indexed keywords

BIOTECHNOLOGY; CELLS; CYTOLOGY; IMMUNOLOGY; MICROORGANISMS; TISSUE;

ANTI-INFLAMMATORY PROPERTIES; IMMUNOREGULATION; INFLAMMATION; INTERACTIONS WITH IMMUNE CELLS; LACTOFERRIN RECEPTORS;

PROTEINS;

LACTOFERRIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; CELL INTERACTION; CONFERENCE PAPER; DOWN REGULATION; ENDOCYTOSIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR INTERACTION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; LACTOFERRIN; SIGNAL TRANSDUCTION;

EID: 33748416650     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O06-045     Document Type: Conference Paper

References (91)

1. Afeltra, A., Caccavo, D., Ferri, G.M., Adessi, M.A., De Rosa, F.G., Amoroso, A., and Bonomo, L. 1997. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin. Exp. Immunol. 109: 279-285. doi:10.1046/j.1365-2249.1997.4351333.x. PMID: 9276523.
2. Annane, D., Bellissant, E., and Cavaillon, J.M. 2005. Septic shock. Lancet, 365: 63-78. doi:10.1016/S0140-6736(04)17667-8. PMID: 15639681.
3. Appelmelk, B.J., An, Y.Q., Geerts, M., Thijs, B.G., De Boer, H.A., MacLaren, D.M., et al. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62: 2628-2632. PMID: 8188389.
4. Artym, J., Zimecki, M., and Kruzel, M.L. 2003a. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology, 207: 197-205. doi:10.1078/0171-2985-00233. PMID: 12777061.
5. Artym, J., Zimecki, M., Paprocka, M., and Kruzel, M.L. 2003b. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 89: 9-15. doi:10.1016/S0165-2478(03)00102-0. PMID: 12946859.
6. Baker, E.N., and Baker, H.M. 2005. Lactoferrin molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 62: 2531-2539. doi:10.1007/s00018-005-5368-9. PMID: 16261257.
7. Baveye, S., Elass, E., Fernig, D.G., Blanquart, C., Mazurier, J., and Legrand, D. 2000a. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun. 68: 6519-6525. doi:10.1128/IAI.68.12.6519-6525.2000. PMID: 11083760.
8. Baveye, S., Elass, E., Mazurier, J., and Legrand, D. 2000b. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett. 469: 5-8. doi:10.1016/S0014-5793(00)01243-6. PMID: 10708745.
9. Bennett, R.M., and Kokocinski, T. 1978. Lactoferrin content of peripheral blood cells. Br. J. Haematol. 39: 509-521. PMID: 359033.
10. Bi, B.Y., Liu, J.L., Legrand, D., Roche, A.C., Capron, M., Spik, G., and Mazurier, J. 1996. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line. Eur. J. Cell Biol. 69: 288-296. PMID: 8900493.
11. Birgens, H.S., Kristensen, L.O., Borregaard, N., Karle, H., and Hansen, N.E. 1988. Lactoferrin-mediated transfer of iron to in-tracellular ferritin in human monocytes. Eur. J. Haematol. 41: 52-57. PMID: 3402586.
12. Brandenburg, K., Jurgens, G., Muller, M., Fukuoka, S., and Koch, M.H. 2001. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382: 1215-1225. doi:10.1515/BC.2001. 152. PMID: 11592403.
13. Breton-Gorius, J., Mason, D.Y., Buriot, D., Vilde, J.-L., and Griscelli, M.D. 1980. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Am. J. Pathol. 99: 413-428. PMID: 6155073.
14. Britigan, B.E., Serody, J.S., Hayek, M.B., Charniga, L.M., and Cohen, M.S. 1991. Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation. J. Immunol. 147: 4271-4277. PMID: 1661314.
15. Britigan, B.E., Lewis, T.S., Waldschmidt, M., McCormick, M.L., and Krieg, A.M. 2001. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167: 2921-2928. PMID: 11509640.
16. Broxmeyer, H.E., Williams, D.E., Hangoc, G., Cooper, S., Gentile, P., Shen, R.N., et al. 1987. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells, 13: 31-48. PMID: 3499193.
17. Damiens, E., El Yazidi, I., Mazurier, J., Elass-Rochard, E., Duthille, I., Spik, G., and Boilly-Marer, Y. 1998. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line. Eur. J. Cell Biol. 77: 344-351. PMID: 9930659.
18. Delehedde, M., Lyon, M., Sergeant, N., Rahmoune, H., and Fernig, D.G. 2001. Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J. Mammary Gland Biol. Neoplasia, 6: 253-273. doi:10.1023/A:1011367423085. PMID: 11547896.
19. Deriy, L.V., Chor, J., and Thomas, L.L. 2000. Surface expression of lactoferrin by resting neutrophils. Biochem. Biophys. Res. Commun. 275: 241-246. doi:10.1006/bbrc.2000.3284. PMID: 10944471.
20. Dhennin-Duthille, I., Masson, M., Damiens, E., Fillebeen, C., Spik, G., and Mazurier, J. 2000. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell. Biochem. 79: 583-593. doi:10.1002/1097-4644(20001215) 79:4<583::AID-JCB70>3.0.CO;2-9. PMID: 10996849.
21. Elass, E., Masson, M., Mazurier, J., and Legrand, D. 2002. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70: 1860-1866. doi:10.1128/IAI.70.4.1860-1866.2002. PMID: 11895948.
22. Elass-Rochard, E., Legrand, D., Salmon, V., Roseanu, A., Trif, M., Tobias, P.S., et al. 1998. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66: 486-491. PMID: 9453600.
23. Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V., Motas, C., et al. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to E. coli 055B5 lipopolysaccharide. Biochem. J. 312: 839-845. PMID: 8554529.
24. Fillebeen, C., Descamps, L., Dehouck, M.P., Fenart, L., Benaïssa, M., Spik, G., et al. 1999. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 274: 7011-7017. doi:10.1074/jbc.274.11. 7011. PMID: 10066755.
25. Frydecka, I., Zimecki, M., Bocko, D., Kosmaczewska, A., Teodorowska, R., Ciszak, L., et al. 2002. Lactoferrin-induced up-regulation of ζ (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res. 22: 1897-1901. PMID: 12168890.
26. Gahr, M., Speer, C.P., Damerau, B., and Sawatzki, G. 1991. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukoc. Biol. 49: 427-433. PMID: 1849951.
27. Gliemann, J. 1998. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol. Chem. 379: 951-964. PMID: 9792428.
28. Grey, A., Banovic, T., Zhu, Q., Watson, M., Gallon, K., Palmano, K., et al. 2004. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18: 2268-2278. doi:10.1210/me.2003-0456. PMID: 15178744.
29. Groot, F., Geijtenbeek, T.B., Sanders, R.W., Baldwin, C.E., Sanchez-Hernandez, M., Floris, R., et al. 2005. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79: 3009-3015. doi:10.1128/JVI.79.5.3009- 3015.2005. PMID: 15709021.
30. Guillen, C., McInnes, I.B., Vaughan, D.M., Kommajosyula, S., Van Berkel, P.H., Leung, B.P., et al. 2002. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168: 3950-3957. PMID: 11937551.
31. Haversen, L., Ohlsson, B.G., Hahn-Zoric, M., Hanson, L.A., and Mattsby-Baltzer, I. 2002. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappaB. Cell. Immunol. 220: 83-95. PMID: 12657243.
32. He, J., and Furmanski, P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature (London), 373: 721-724. doi:10.1038/373721a0. PMID: 7854459.
33. He, S., McEuen, A.R., Blewett, S.A., Li, P., Buckley, M.G., Leufkens, P., and Walls, A.F. 2003. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem. Pharmacol. 65: 1007-1015. doi:10.1016/80006-2952(02)01651- 9. PMID: 12623133.
34. Herz, J., and Strickland, D.K. 2001. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108: 779-784. doi:10.1172/JCI200113992. PMID: 11560943.
35. Hovanessian, A.G., Puvion-Dutilleul, F., Nisole, S., Svab, J., Perret, E., Deng, J.S., and Krust, B. 2000. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp. Cell Res. 261: 312-328. doi:10.1006/excr.2000.5071. PMID: 11112338.
36. Hwang, S.A., Kruzel, M.L., and Actor, J.K. 2005. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Int. Immunopharmacol. 5: 591-599. doi:10.1016/j.intimp.2004.11.006. PMID: 15683854.
37. Ishii, K., Takamura, N., Shinohara, M., Wakui, N., Shin, H., Sumino, Y., et al. 2003. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 25: 226-233. PMID: 12697243.
38. Ismail, M., and Brock, J.H. 1993. Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release. J. Biol. Chem. 268: 21618-21625. PMID: 8408013.
39. Japelj, B., Pristov-Ek, P., Majerle, A., and Jerala, R. 2005. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J. Biol. Chem. 280: 16955-16961. doi:10.1074/jbc. M500266200. PMID: 15687491.
40. Kai, K., Komine, K., Komine, Y., Kuroishi, T., Kozutsumi, T., Kobayashi, J., et al. 2002. Lactoferrin stimulates A Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland. Microbiol. Immunol. 46: 187-194. PMID: 12008928.
41. Kijlstra, A., and Jeurissen, S.H. 1982. Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology, 47: 263-270. PMID: 6922088.
42. Kleinman, H.K., Weeks, B.S., Cannon. F.B., Sweeney, T.M., Sephel, G.C., Clement, B., et al. 1991. Identification of a 110-kDa nonintegrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide. Arch. Biochem. Biophys. 290: 320-325. doi:10.1016/0003-9861(91)90547-V. PMID: 1834017.
43. Kuhara, T., Iigo, M., Itoh, T., Ushida, Y., Sekine, K., Terada, N., et al. 2000. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr. Cancer, 38: 192-199. PMID: 11525597.
44. Kurose, I., Yamada, T., Wolf, R., and Granger, D.N. 1994. P-selectin-dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin. J. Leukoc. Biol. 55: 771-777. PMID: 7515095.
45. Larrucea, S., Gonzalez-Rubio, C., Cambronero, R., Ballou, B., Bonay, P., Lopez-Granados, E., et al. 1998. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J. Biol. Chem. 273: 31718-31725. doi:10.1074/jbc.273.48.31718. PMID: 9822633.
46. Lee, W.J., Farmer, J.L., Hilty, M., and Kim, Y.B. 1998. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66: 1421-1426. PMID: 9529062.
47. Legrand, D., Elass, E., Carpentier, M., and Mazurier, J. 2005. Lactoferrin: a modulator of immune and inflammatory responses. Cell. Mol. Life Sci. 62: 2549-2559. doi: 10.1007/s00018-005-5370-2. PMID: 16261255.
48. Legrand, D., Mazurier, J., Elass, A., Rochard, E., Vergoten, G., Maes, P., et al. 1992. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry, 31: 9243-9251. doi:10.1021/bi00153a018. PMID: 1327110.
49. Legrand, D., van Berkel, P.H., Salmon, V., van Veen, H.A., Slomianny, M.C., Nuijens, J.H., and Spik, G. 1997. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J. 327: 841-846. PMID: 9581564.
50. Legrand, D., Vigié, K., Said, E.A., Elass, E., Masson, M., Slomianny, M.C., et al. 2004. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271: 303-317. doi:10.l046/j.1432-1033.2003.03929.x. PMID: 14717698.
51. Leveugle, B., Mazurier, J., Legrand, D., Mazurier, C., Montreuil, J., and Spik, G. 1993. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem. 213: 1205-1211. doi:10.1111/j.1432-1033. 1993.tb17871.x. PMID: 8389297.
52. Lobie, P.E., Mertani, H., Morel, G., Marales-Bustos, O., Noestedt, G., and Waters, M.J. 1994. Receptor-mediated nuclear translocation of growth hormone. J. Biol. Chem. 269: 21330-21339. PMID: 8063758.
53. Maaks, S., Yan, H.Z., and Wood, W.G. 1989. Development and evaluation of luminescence based sandwich assay for plasma lactoferrin as a marker for sepsis and bacterial infections in pediatric medicine. J. Biolumin. Chemilumin. 3: 221-226.
54. Machnicki, M., Zimecki, M., and Zagulski, T. 1993. Lactoferrin regulates the release of tumour necrosis factor α and interleukin 6 in vivo. Int. J. Exp. Pathol. 74: 433-439. PMID: 8217778.
55. Maneva, A.I., Sirakov, L.M., and Manev, V.V. 1983. Lactoferrin binding to neutrophilic polymorphonuclear leucocytes. Int. J. Biochem. 15: 981-984. doi:10.1016/0020-711X(83)90179-9. PMID: 6884573.
56. Mann, D.M., Romm, E., and Migliorini, M. 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269: 23661-23667. PMID: 8089135.
57. Masson, P.L., Heremans, J.F., and Schonne, E. 1969. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658. doi:10.1084/jem.130.3.643. PMID: 4979954.
58. Mazurier, J., Legrand, D., Hu, W.L., Montreuil, J., and Spik, G. 1989. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Eur. J. Biochem. 179: 481-487. doi:10.1111/j.1432-1033.1989.tb14578.x. PMID: 2537213.
59. McAbee, D.D., Jiang, X., and Walsh, K.B. 2000. Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties. Biochem. J. 348: 113-117. doi:10.1042/0264-6021:3480113. PMID: 10794721.
60. Meilinger, M., Haumer, M., Szakmary, K.A., Steinbock, F., Scheiber, B., Goldenberg, H., and Huettinger, M. 1995. Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein/α2-macroglobulin receptor and transport to endosomes. FEBS Lett. 360: 70-74. doi:10.1016/0014-5793(95)00082-K. PMID: 7533106.
61. Miyauchi, H., Hashimoto, S., Nakajima, M., Shinoda, I., Fukuwatari, Y., and Hayasawa, H. 1998. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell. Immunol. 187: 34-37. doi:10.1006/cimm.1997.1246. PMID: 9682001.
62. Montreuil, J., Tonnelat, J., and Mullet, S. 1960. Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme. Biochim. Biophys. Acta, 45: 413-421. doi:10.1016/0006-3002(60) 91478-5. PMID: 13772242.
63. Nisole, S., Krust, B., Dam, E., Bianco, A., Seddiki, N., Loaec, S., et al. 2000. The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymphocyte- and macrophage-tropic HIV to permissive cells. AIDS Res. Hum. Retroviruses, 16: 237-249. doi:10.1089/088922200309331. PMID: 10710212.
64. Nisole, S., Said, E.A., Mische, C., Prévost, M.C., Krust, B., Bouvet, P., et al. 2002. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J. Biol. Chem. 277: 20877-20886. doi:10.1074/jbc.M110024200. PMID: 11919179.
65. Oh, S.M., Hahm, D.H., Kim, I.H., and Choi, S.Y. 2001. Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J. Biol. Chem. 276: 42575-42579. doi:10.1074/jbc.M107724200. PMID: 11535608.
66. Oh, S.M., Pyo, C.W., Kim, Y., and Choi, S.Y. 2004. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-κ B activation cascade. Oncogene, 23: 8282-8291. doi:10.1038/sj.onc.1208021. PMID: 15378004.
67. Rainard, P. 1993. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology, 79: 648-652. PMID: 8406591.
68. Raphael, G.D., Davis, J.L., Fox, P.C., Malech, H.L., Gallin, J.I., Baraniuk, J.N., and Kaliner, M.A. 1989. Glandular secretion of lactoferrin in a patient with neutrophil lactoferrin deficiency. J. Allergy Clin. Immunol. 84: 914-919. doi:10.1016/0091-6749(89)90389-8. PMID: 2600325.
69. Rycyzyn, M.A., and Clevenger, C. 2002. The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc. Natl. Acad. Sci. U.S.A. 99: 6790-6795. doi:10.1073/pnas.092160699. PMID: 11997457.
70. Said, E.A., Krust, B., Nisole, S., Svab, J., Briand, J.P., and Hovanessian, A.G. 2002. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J. Biol. Chem. 277: 37492-37502. doi:10.1074/jbc.M201194200. PMID: 12147681.
71. Schaible, U.E., Collins, H.L., Priem, F., and Kaufmann, S.H. 2002. Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196: 1507-1513. doi:10.1084/jem.20020897. PMID: 12461085.
72. Semenkovich, C.F., Ostlund, R.E., Olson, M.O., and Yang, J.W. 1990. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry, 29: 9708-9713. doi:10.1021/bi00493a028. PMID: 2176855.
73. Shibata, Y., Muramatsu, T., Hirai, M., Inui, T., Kimura, T., Saito, H., et al. 2002. Nuclear targeting by the growth factor midkine. Mol. Cell. Biol. 22: 6788-6796. doi:10.1128/MCB.22.19.6788-6796.2002. PMID: 12215536.
74. Shimizu, K., Matsuzawa, H., Okada, K., Tazume, S., Dosako, S., Kawasaki, Y., et al. 1996. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol. 141: 1875-1889. doi:10.1007/BF01718201. PMID: 8920822.
75. Shinoda, I., Takase, M., Fukuwatari, Y., Shimamura, S., Koller, M., and Konig, W. 1996. Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci. Biotechnol. Biochem. 60: 521-523. PMID: 8901116.
76. Sorimachi, K., Akimoto, K., Hattori, Y., Leiri, T., and Niwa, A. 1997. Activation of macrophages by lactoferrin: secretion of TNF-α, IL-8 and NO. Biochem. Mol. Biol. Int. 43: 79-87. PMID: 9315285.
77. Srivastava, M., and Pollard, H.B. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13: 1911-1922. PMID: 10544174.
78. Suzuki, Y.A., Lopez, V., and Lönnerdal, B. 2005. Mammalian lactoferrin receptors: structure and function. Cell. Mol. Life Sci. 62: 2560-2575. doi:10.1007/s00018-005-5371-l. PMID: 16261254.
79. Suzuki, Y.A., Shin, K., and Lönnerdal, B. 2001. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry, 40: 15771-15779. doi:10.1021/bi0155899. PMID: 11747454.
80. Szuster-Ciesielska, A., Kaminska, T., and Kandefer-Szerszen, M. 1995. Phagocytosis-enhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo. Arch. Vet. Pol. 35: 63-71. PMID: 9071453.
81. Takayama, Y., Takahashi, H., Mizumachi, K., and Takezawa, T. 2003. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J. Biol. Chem. 278: 22112-22118. doi:10.1074/jbc.M300894200. PMID: 12672816.
82. Take, M., Tsutsui, J., Obama, H., Ozawa, M., Nakayama, T., Maruyama, I., et al. 1994. Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM). J. Biochem. (Tokyo), 116: 1063-1068. PMID: 7896734.
83. Togawa, J., Nagase, H., Tanaka, K., Inamori, M., Nakajima, A., Ueno, N., et al. 2002. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17: 1291-1298. doi:10.1046/j.1l440-1746.2002.02868.x. PMID: 12423274.
84. Valenti, P., and Antonini, G. 2005. Lactoferrin: an important host defence against microbial and viral attack. Cell. Mol. Life Sci. 62: 2576-2587. doi:10.1007/s00018-005-5372-0. PMID: 16261253.
85. Van Hooijdonk, A.C., Kussendrager, K.D., and Steijns, J.M. 2000. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br. J. Nutr. 84: S127-S134. PMID: 11242457.
86. van Snick, J.L., Markowetz, B., and Massen, P.L. 1977. The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin. J. Exp. Med. 146: 817-827. doi:10.1084/jem.146.3.817. PMID: 894189.
87. Willnow, T.E., Goldstein, J.L., Orth, K., Brown, M.S., and Herz, J. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267: 26172-26180. PMID: 1464627.
88. Zagulski, T., Lipinski, P., Zagulska, A., Broniek, S., and Jarzabek, Z. 1989. Lactoferrin can protect mice against a lethal dose of E. coli in experimental infection in vivo. Br. J. Exp. Pathol. 70: 697-704. PMID: 2690922.
89. Zimecki, M., Kocieba, M., and Kruzel, M. 2002. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology, 205: 120-131. doi:10.1078/0171-2985-00115. PMID: 11999341.
90. Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z., Montreuil, J., and Spik, G. 1991. Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8- murine thymocytes. Immunol. Lett. 30: 119-123. doi:10.1016/0165-2478(91)90099-V. PMID: 1683650.
91. Zimecki, M., Mazurier, J., Spik, G., and Kapp, J.A. 1995. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology, 86: 122-127. PMID: 7590872.